Ikterus pada kolestasis merupakan refleksi dari keadaan patologis yang serius. Kolestasis- 
Jaundice can occured in neonatal sepsis. Despite it's recognition since the 19th century, only recently had studies reveal the role of mediators in pathophysiology of 1 Cholestasis are frequently found in sepsis therefore researchers have intensively seek for the underlying mechanism at molecular level. 2, 3 Cholestasis is a clinical syndrome caused by obstruction of biliary outflow with clinical manifestation as follow : jaundice (icteric), dark colored urine, acholic feces (permanent/fluctuative) 46 and laboratory parameters are an increased in direct bilirubin more than 20% of total bilirubin. 7 As for sepsis, it is a severe clinical con dition for neonates. Abruption of cholestasis sepsis represents more severe condition in sepsis. Prolonged and incapacitating cholestasis will increased liver disfunction progressing to liver failure, theoretically liver failure is the begining of other organ failure.
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Justified diagnostic approach are required in management of intrahepatic cholestasis in neonatal sepsis at early stage to prevent sequelle so the child can grow and develop optimally.
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This study aim to find out the incidence of intrahepatic cholestasis in neonatal sepsis patients, associated risk factors and mortality rate of cholestasis sepsis in neonates.
METHODS
Design of study is prospective cohort with no equivalent control group. It was perform by daily clinical assessment of neonatal sepsis patients from the first day of admission until they are released from or died at the Neonatology ward Cipto Mangunkusumo General National Hospital. The study took place in Neonatology ward and Neonatal Intensive Care Unit (NICU) Department of Child Health Faculty of Medicine University of IndonesiaCipto Mangunkusumo General National Hospital. Duration of study is 5 months, from February 2007 to June 2007.
Inclucion criteria of subjects: neonates with suspect sepsis, no previous record of antibiotics or antifungal treatment, and had permission from the parents. Exclusion criteria are: off coloured three portion feces, possible metabolic disorders or chromosomal aberation based on anamnesis and physical examination, family history of intrahepatic disease with unknown cause or recurrence, evidence of viral or parasitic infection, possible immunological defect or blood dyscrasia based on anamnesis and physical examination; history of hypoperfused shock.
In all patients with suspect neonatal sepsis, data on identity was recorded. They are name, medical record number, birth date/age, sex, birth weight, length at birth, home address, date of admission, refered or born in another hospital, and other cholestatic risk factors that was tested in this study. Informed concent was obtained from parents as sign of agreement to participate in the study. Patients were then classified as cholestasis-sepsis group and noncholestasissepsis group.
Peripheral venous blood were withdrawn from the patients with a volume of 2,5 ml and diagnostic work up was performed on the first day of admission: complete blood count, level of Creactive protein (CRP), IT ratio and blood culture. Urine bilirubin test were performed on the third, fifth, seventh, ninth, eleventh, and thirteenth day unless positive 1 result had been obtain earlier than one of the day mentioned, then the urine biliary test was stopped. Afterwards, further blood tests were performed (another 2.5 ml of peripheral blood were drawn) in order to check total bilirubin concentration, direct bilirubin concentration, ALT, AST and γGT.
Proceeding management of the patients were adjusted accordingly to standard management procedure of neonatal sepsis at Neonatology Division Department of Child Health Faculty of Medicine University of IndonesiaCipto Mangunkusumo National General Hospital.
Two categories used to classified neonatal sepsis which is suspected infection and proven infection. Proven infection is based on the finding of microbial etiology, while suspected infection is based on risk factors, clinical symptoms and signs and other laboratory result.
Data was analysed using SPSS 12.00, for average number, SD, and 95% confidence interval. Association between two qualitative variable was analysed with Chi Square test or Fisher exact test. Association between qualitative and quantitative variable was analysed using Student t test or ANOVA.
RESULTS
From 157 suspect sepsis patients, 19 were excluded from the study. Amongst the exluded cases 5 were uncompliance (they returned home before the successive 14 days urine tests, in these cases there were no evidence of cholestasis), 2 patients were given anticonvulsant drugs, 3 patients were identified with congenital heart defects, 2 patients with down syndrome or facial dysmorphic and 7 patients died before compeleted the examinations.
From 138 subjects included in this study, there were some with exceptionally special circumstances. They were 15 patients with sterile blood culture result, 2 patients with anemia post natal required pack red blood cells transfusion, 12 with metabolic acidosis or hypoglycemia, and 9 with neurological deficits.
According to onset of neonatal sepsis, 118 subjects were early onset sepsis and the other 20 were late onset. 112 subjects (81,2%) were born at Cipto Mangunkusumo Hospital while 26 other (18,8%) were born at another hospital.
From Table 1 the gestational age of most subjects were less than 38 weeks, with percentage of 55,8% (77 subjects). Most cases were low birth weight babies (less than 2500 grams) with 24 cases were very low birth weight (17,4%). 80 subjects were male with percentage of 58,0% and 58 female (42,0%). Age of patients at the time of sepsis onset mostly are 1 days with total number of 100 patients. Duration of hospitalization mostly are between 15 to 30 days. Laboratory result showed total leucocyte number between 5000-10.000/μL were found in 54 subjects (39,1 %). Thrombocyte count of less than 100.000/μL were found in 103 subjects (74,6 %). CRP level more than 10 mg/dL were found in 123 subjects (89,1 %). IT ratio of more than 0,10 were found in 102 kasus (73,9 %). Table 4 showed that 91 proven cholestasis sepsis subjects have increased direct bilirubin concentration about 55,3% from totalbilirubin concentration. Average concentration for ALT, AST, and γGT were within normal ranges at the beginning of cholestasis. Table 5 showed associated risk factors with the occurence of cholestasis : sex, age at the time of admission, birth place, birth weight, birth height, prematurity, low birth weight, early onset sepsis. Table 6 showed risk factors from laboratory result as sepsis indicator at the time of admission: leucocyte number, thrombocyte number, CRP concentration, and IT ratio with occurrence of cholestasis. Result of urine bilirubin were classified as positive 1, 2 and 3. Picture 1 showed that most neonatal sepsis had postive 1 result on day7 with 17 subjects of total 91 cholestasis subjects. The onset of cholestasis in neonatal sepsis with median on day7 from 91 cholestasis subjects. Number of neonatal mortality due to sepsis in this study is 59(42,8%). While mortality rate of cholestasis sepsis from this study is 48 from 91 cholestasis subjects (52,8%) with p = 0,002, RR = 2,25 (1,30 -3,92) . 
DISCUSSION
Most neonatal with sepsis in this study have low birth weight which is less than 2500 grams as many as 77 subjects (55,8%), with peak birth weight group between 15002499 grams. According to study by Shamir 10 et al, birth weight of less than 2500 grams group are the highest population with gram negative sepsis. Other finding in this study that is in accordance with study by Shamir et al is that gestational age of less than 38 weeks are the most frequent group with gram negative sepsis. Preterm neonates (gestational age < 38 weeks) are immature, their immune system are inadequate therefore they are susceptible to infection.
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In this study we found the incidence of neonatal cholestasis sepsis is 65,9%, lower compare to previous study done by Oswari et al. 12 The study by Oswari was a retrospective study showed occurrence of cholestasis in 47 sepsis neonates at NICU and Neonatology ward Cipto Mangunkusumo National General Hospital with percentage of 74,5% proven sepsis. The difference with our study, we use larger sample size and included both proven and clinical sepsis. There hasn'nt been any report from other countries about the incidence of cholestasis sepsis either proven or clinical sepsis.
Microbial etiology spectrum of neonatal sepsis differs in each hospital. In this study microbial etiology of neonatal sepsis is gram negative bacteria (82,6%), with the most frequently found Acinetobacter calcoaceticus (41,3%) followed by Enterobacter aerogenes (15,9%) and Klebsiella pneumoniae (10,9%). Our result is similar with reports from several refferrence that stated most neonatal sepsis are caused by gram negative bacteria.
13 Nevertheless in our study, Fisher exact test failed to reveal significant correlation between gram negative bacteria and cholestasis occurrence. From 91 cholestasis subjects, direct bilirubin con centration increased 55,3% from total bilirubin. Tiker 13 et al found increased direct bilirubin 44,1% from total bilirubin (average direct bilirubin is 12,9 mg/dL, from average total bilirubin 29,2 mg/dL). Shamir 10 et al found increased direct bilirubin 29,7% from total bilirubin, (direct bilirubin 3,3 ± 4,7 mg/dL, from total bilirubin 11,1 ± 5,2 mg/dL). Increased level of direct bilirubin in this study is higher, this is due to possible gram negative bacteria sepsis are different or because difference in duration of fasting, therefore further research is required. The effect of duration of fasting in gram negative sepsis neonates are the longer period of fasting will increased direct bilirubin more pronounced than shorter fasting period.
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In our study, most cases of neonatal cholestasis sepsis (52,8%) ended with mortality. From this result, relative risk of neonatal cholestasis is 2.25 (1, 303, 92) . The presence of cholestasis in neonatal sepsis implicates in increased mortality rate, therefore cholestasis can be used as prognostic factor for mortality in neonatal sepsis patients. Up till now, lack of studies addressing this issue specifically.
It is concluded that the incidence of cholestasis sepsis in neonates at Neonatology ward and NICU Cipto Mangunkusumo Hospital is 65,9% with most frequent etiology is Acinetobacter calcoaceticus (40,6%). Risk factors associated with the occurrence of neonatal cholestasis sepsis are statistically insignificant, therefore further study is required. Onset of intrahepatic cholestasis in neonatal sepsis occured mostly on day7. Mortality rate of neonatal cholestasis sepsis is 52,8%.
